Page last updated: 2024-12-06

nerisopam

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Nerisopam: structure given in first source; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65875
CHEMBL ID2104732
SCHEMBL ID1004757
MeSH IDM0170843

Synonyms (22)

Synonym
gyki-52322
nerisopam
egis-6775
1-(4-aminophenyl)-7,8-dimethoxy-4-methyl-5h-2,3-benzodiazepine
gyki 52322
5h-2,3-benzodiazepine, 1-(4-aminophenyl)-7,8-dimethoxy-4-methyl-
1-(p-aminophenyl)-7,8-dimethoxy-4-methyl-5h-2,3-benzodiazepine
benzenamine, 4-(7,8-dimethoxy-4-methyl-5h-2,3-benzodiazepin-1-yl)-
1-(4-aminophenyl)-4-methyl-7,8-dimethoxy-5h-2,3-benzodiazepine
nerisopam [inn]
4-(7,8-dimethoxy-4-methyl-5h-2,3-benzodiazepin-1-yl)aniline
18q4o339ag ,
102771-12-0
unii-18q4o339ag
CHEMBL2104732
SCHEMBL1004757
WWQDEXGFYVSTCX-UHFFFAOYSA-N
DTXSID90145499
benzenamine, 4-(7,8-dimethoxy-4-methyl-5h-2,3-benzodiazepin-1-yl)-;benzenamine, 4-(7,8-dimethoxy-4-methyl-5h-2,3-benzodiazepin-1-yl)-
4-(7,8-dimethoxy-4-methyl-5h-benzo[d][1,2]diazepin-1-yl)aniline
Q6996288
AKOS040749015

Research Excerpts

Pharmacokinetics

Nerisopam shows two compartmental pharmacokinetic behaviour. N-acetyl metabolite (EGIS-7649) shows one compartmental behaviour. Three doses were administered to the rats during the study.

ExcerptReferenceRelevance
"Three doses were administered to the rats during the pharmacokinetic study of nerisopam and the plasma concentrations of nerisopam and its N-acetyl metabolite were determined parallelly by means of validated SPE-HPLC method developed by the authors."( [Pharmacokinetic study of nerisopam and its n-acetyl metabolite in rats].
Ary, K; Gachályi, B; Grézal, G; Klebovich, I; Renczes, G; Riesz, T; Róna, K,
)
0.66
"It was established during the human phase I study of nerisopam, a new anxiolytic drug, that nerisopam (EGIS-6775) shows two, while N-acetyl metabolite (EGIS-7649) shows one compartmental pharmacokinetic behaviour."( [Human pharmacokinetic study of nerisopam and its n-acetyl metabolite].
Ary, K; Csörgö, M; Drabant, S; Gachályi, B; Grézal, G; Klebovich, I; Renczes, G; Róna, K,
)
0.66
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's4 (57.14)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]